|
Vitamin K Epoxide Reductases
|
D08.811.682.690.708.961 |
|
|
Mixed Function Oxygenases
|
D08.811.682.690.708 |
|
|
Retinol O-Fatty-Acyltransferase
|
D08.811.913.050.646 |
|
|
Protein Phosphatase 1
|
D054645 |
[A eukayrotic protein serine-threonine phosphatase subtype that dephosphorylates a wide variety of cellular proteins. The enzyme is comprised of a catalytic subunit and regulatory subunit. Several isoforms of the protein phosphatase catalytic subunit exist due to the presence of multiple genes and the alternative splicing of their mRNAs. A large number of proteins have been shown to act as regulatory subunits for this enzyme. Many of the regulatory subunits have additional cellular functions.
] |
|
Barbiturates
|
D03.383.742.698.253 |
|
|
Estrus Synchronization
|
G08.686.195.500.500 |
|
|
Estrus
|
G08.686.195.500 |
|
|
Meglutol
|
D015093 |
[An antilipemic agent which lowers cholesterol, triglycerides, serum beta-lipoproteins and phospholipids. It acts by interfering with the enzymatic steps involved in the conversion of acetate to hydroxymethylglutaryl coenzyme A as well as inhibiting the activity of HYDROXYMETHYLGLUTARYL COA REDUCTASES which is the rate limiting enzyme in the biosynthesis of cholesterol.
] |
|
Antigens, CD1
|
D23.101.100.894.080 |
|
|
3-Hydroxyacyl CoA Dehydrogenases
|
D015094 |
[Enzymes that reversibly catalyze the oxidation of a 3-hydroxyacyl CoA to 3-ketoacyl CoA in the presence of NAD. They are key enzymes in the oxidation of fatty acids and in mitochondrial fatty acid synthesis.
] |
|
Scotoma
|
C23.888.592.763.941.811 |
|
|
Vision Disorders
|
C23.888.592.763.941 |
|
|
beta-Alanine
|
D015091 |
[An amino acid formed in vivo by the degradation of dihydrouracil and carnosine. Since neuronal uptake and neuronal receptor sensitivity to beta-alanine have been demonstrated, the compound may be a false transmitter replacing GAMMA-AMINOBUTYRIC ACID. A rare genetic disorder, hyper-beta-alaninemia, has been reported.
] |
|
Integrin alpha4beta1
|
D039041 |
[Integrin alpha4beta1 is a FIBRONECTIN and VCAM-1 receptor present on LYMPHOCYTES; MONOCYTES; EOSINOPHILS; NK CELLS and thymocytes. It is involved in both cell-cell and cell- EXTRACELLULAR MATRIX adhesion and plays a role in INFLAMMATION, hematopoietic cell homing and immune function, and has been implicated in skeletal MYOGENESIS; NEURAL CREST migration and proliferation, lymphocyte maturation and morphogenesis of the PLACENTA and HEART.
] |
|
3-Deazauridine
|
D015092 |
[4-Hydroxy-1-(beta-D-ribofuranosyl)-2-pyridinone. Analog of uridine lacking a ring-nitrogen in the 3-position. Functions as an antineoplastic agent.
] |
|
Therapeutic Index, Drug
|
E01.789.800.665.500 |
|
|
Therapeutic Index
|
E01.789.800.665 |
|
|
3-Mercaptopropionic Acid
|
D015097 |
[An inhibitor of glutamate decarboxylase. It decreases the GAMMA-AMINOBUTYRIC ACID concentration in the brain, thereby causing convulsions.
] |
|
3-Methoxy-4-hydroxyphenylethanol
|
D015098 |
[Metabolite of serotonin and norepinephrine.
] |
|
3-Hydroxyanthranilic Acid
|
D015095 |
[An oxidation product of tryptophan metabolism. It may be a free radical scavenger and a carcinogen.
] |
